Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6420)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2017 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mehrzad M, Tuktamyshov R, Mehrzad R. Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review. World J Cardiol 2017; 9(9): 761-772 [PMID: 29081910 DOI: 10.4330/wjc.v9.i9.761] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v9/i9/761.htm |
| Number | Citing Articles |
| 1 |
Yi Li, Zhenyang Liang, Lei Qin, Mian Wang, Xianzhao Wang, Huanyi Zhang, Yin Liu, Yan Li, Zhisheng Jia, Limin Liu, Hongyan Zhang, Jun Luo, Songwu Dong, Jincheng Guo, Hengqing Zhu, Shengli Li, Haijun Zheng, Lijun Liu, Yanqing Wu, Yiming Zhong, Miaohan Qiu, Yaling Han, Gregg W Stone. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. The Lancet 2022; 400(10366): 1847 doi: 10.1016/S0140-6736(22)01999-7
|
| 2 |
Karla de Castro Figueiredo Bordon, Camila Takeno Cologna, Elisa Corrêa Fornari-Baldo, Ernesto Lopes Pinheiro-Júnior, Felipe Augusto Cerni, Fernanda Gobbi Amorim, Fernando Antonio Pino Anjolette, Francielle Almeida Cordeiro, Gisele Adriano Wiezel, Iara Aimê Cardoso, Isabela Gobbo Ferreira, Isadora Sousa de Oliveira, Johara Boldrini-França, Manuela Berto Pucca, Mateus Amaral Baldo, Eliane Candiani Arantes. From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01132
|
| 3 |
Gregg W. Stone, Marco Valgimigli, David Erlinge, Yaling Han, Philippe Gabriel Steg, Rod H. Stables, Enrico Frigoli, Stefan K. James, Yi Li, Patrick Goldstein, Roxana Mehran, Ghazaleh Mehdipoor, Aaron Crowley, Shmuel Chen, Björn Redfors, Clayton Snyder, Zhipeng Zhou, Behnood Bikdeli. Bivalirudin vs Heparin Anticoagulation in STEMI. Journal of the American College of Cardiology 2024; 84(16): 1512 doi: 10.1016/j.jacc.2024.07.045
|
| 4 |
Lina Chai, Jinjun Liu, Yapei Zhang, Mengying Zhang, Zhenzhen Wang, Yiping Wu, Zhichao Bai, Zhenpeng Qin. Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients. Experimental and Therapeutic Medicine 2023; 26(5) doi: 10.3892/etm.2023.12229
|
| 5 |
Antonio Santana-Otero, Alan Harper, Neil Telling, Daniel Ortega, David Cabrera. Magnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole blood. Nanoscale 2024; 16(7): 3534 doi: 10.1039/D3NR02593D
|
| 6 |
Behnood Bikdeli, Thomas McAndrew, Aaron Crowley, Shmuel Chen, Ghazaleh Mehdipoor, Björn Redfors, Yangbo Liu, Zixuan Zhang, Mengdan Liu, Yiran Zhang, Dominic P. Francese, David Erlinge, Stefan K. James, Yaling Han, Yi Li, Adnan Kastrati, Stefanie Schüpke, Rod H. Stables, Adeel Shahzad, Philippe Gabriel Steg, Patrick Goldstein, Enrico Frigoli, Roxana Mehran, Marco Valgimigli, Gregg W. Stone. Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology. Thrombosis and Haemostasis 2020; 120(02): 348 doi: 10.1055/s-0039-1700872
|